From new leadership to product launches, here are five key updates from spine and orthopedic devicemakers since Jan. 15.

Johnson & Johnson reported better-than-expected quarterly revenue and profit on higher sales of cancer drugs and some medical devices. But shares slipped 3.2% to $143.35 in Wednesday morning trading, ...

Johnson & Johnson executives, on a Wednesday earnings call, did not provide a timeline for when U.S. Varipulse cases will ...

Generators aren't the only equipment that can cause carbon monoxide poisoning. If not cleared, vents and pipes for gas ...

To address these shortages, the FDA has put measures into place, including expedited review processes and the use of enforcement discretion. The FDA also now requires manufacturers to give at least ...

The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...

Surgeons, dentists, and certain specialists can spend hours in a position with their arms stretched forward. Shoulder support ...

The pharma expects a modest financial headwind this year from changes to Medicare prescription drug benefits under the Inflation Reduction Act.

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The Carter County Mayor’s Office has released its weekly update on disaster assistance resources available to residents ...

Prism Johnson Ltd., incorporated in the year 1992, is a Mid Cap company (having a market cap of Rs 7,541.79 Crore) operating in Cement sector. Prism Johnson Ltd. key Products/Revenue Segments include ...